Quest Diagnostics IncorporatedDGXNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+9.4%
5Y CAGR+11.8%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+9.4%/yr
Annual compound
5Y CAGR
+11.8%/yr
Consistent
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 11.13% |
| 2024 | 9.60% |
| 2023 | -13.82% |
| 2022 | 8.51% |
| 2021 | 11.42% |
| 2020 | 6.38% |
| 2019 | 2.32% |
| 2018 | -18.63% |
| 2017 | 4.10% |
| 2016 | 0.12% |